Clinical guidelines, while representing an objective reference to perform correct therapeutic choices, contain grey zones, where recommendations are not supported by solid evidence. In a conference held in Bergamo in October 2018, an attempt was made to highlight some of the main grey zones in Cardiology and, through a comparison between experts, to draw shared conclusions that can illuminate our clinical practice. This manuscript contains the statements of the symposium concerning the controversies in the percutaneous treatment of valvulopathies. The first topic concerns the durability of aortic bioprostheses, comparing percutaneous interventional with surgical experiences. The second issue examines the opportunity to extend percutaneous aortic replacement as standard care to low-risk patients. The last gap in evidence concerns the percutaneous treatment of functional mitral valve insufficiency, with the MitraClip system. The work has also been implemented with evidences deriving from important randomized studies published after the date of the Conference.

Frigerio, M., Fiocca, L., Bedogni, F., Alfieri, O., Margonato, A., Galletti, L., et al. (2020). Grey zones on valvular heart disease: Interventional cardiology versus cardiac surgery. Expert opinion [Grey zones sulla cardiologia interventistica valvolare e cardiochirurgia a confronto. Opinioni degli esperti]. GIORNALE ITALIANO DI CARDIOLOGIA, 21(2), 111-118 [10.1714/3300.32704].

Grey zones on valvular heart disease: Interventional cardiology versus cardiac surgery. Expert opinion [Grey zones sulla cardiologia interventistica valvolare e cardiochirurgia a confronto. Opinioni degli esperti]

Senni M;
2020

Abstract

Clinical guidelines, while representing an objective reference to perform correct therapeutic choices, contain grey zones, where recommendations are not supported by solid evidence. In a conference held in Bergamo in October 2018, an attempt was made to highlight some of the main grey zones in Cardiology and, through a comparison between experts, to draw shared conclusions that can illuminate our clinical practice. This manuscript contains the statements of the symposium concerning the controversies in the percutaneous treatment of valvulopathies. The first topic concerns the durability of aortic bioprostheses, comparing percutaneous interventional with surgical experiences. The second issue examines the opportunity to extend percutaneous aortic replacement as standard care to low-risk patients. The last gap in evidence concerns the percutaneous treatment of functional mitral valve insufficiency, with the MitraClip system. The work has also been implemented with evidences deriving from important randomized studies published after the date of the Conference.
Articolo in rivista - Articolo scientifico
Aortic stenosis; Guidelines; MitraClip; Mitral regurgitation; Transcatheter aortic valve implantation;Valvular heart disease;
Italian
111
118
8
Frigerio, M., Fiocca, L., Bedogni, F., Alfieri, O., Margonato, A., Galletti, L., et al. (2020). Grey zones on valvular heart disease: Interventional cardiology versus cardiac surgery. Expert opinion [Grey zones sulla cardiologia interventistica valvolare e cardiochirurgia a confronto. Opinioni degli esperti]. GIORNALE ITALIANO DI CARDIOLOGIA, 21(2), 111-118 [10.1714/3300.32704].
Frigerio, M; Fiocca, L; Bedogni, F; Alfieri, O; Margonato, A; Galletti, L; Indolfi, C; Senni, M; Grigioni, F
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/372930
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
Social impact